Wenliang Tan Selected Research

Wenliang Tan Research Topics

15	Neoplasms (Cancer) 03/2024 - 01/2017
15	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2017
4	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2017
3	Carcinogenesis 03/2024 - 01/2018
1	Wounds and Injuries (Trauma) 01/2023
1	Hypertension (High Blood Pressure) 02/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 02/2022
1	Syncope (Fainting) 02/2022
1	Alcoholism (Alcohol Abuse) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Cholangiocarcinoma 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018

5	Sorafenib (BAY 43-9006)FDA Link 06/2022 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 03/2024 - 01/2018
2	Circular RNAIBA 03/2024 - 01/2022
2	CateninsIBA 01/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 12/2019
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020 - 01/2017
2	TNF Receptor-Associated Factor 4IBA 12/2020 - 01/2017
1	mRNA VaccinesIBA 02/2024
1	Malondialdehyde (Propanedial)IBA 01/2023
1	lenvatinibIBA 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 02/2022
1	Cyclin D1IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	ZincIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	urinastatin (MR 20)IBA 02/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2019
1	Sincalide FDA Link 12/2018
1	SB 3CT compoundIBA 11/2017

2	Therapeutics 01/2023 - 02/2019
1	Immunotherapy 01/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Radiotherapy 12/2018